Nephros Inc.
NEPH | NASDAQ
$3.26
+$0.09 (+2.84%)
Nov 2, 2026, 9:50 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 44.36 | 210 | -23.07 | -1.61 | -14.39 | -16.50 |
PEG Ratio | 0.03 | -2.01 | 0.29 | -0.02 | 0.68 | -0.69 |
PS Ratio | 2.76 | 1.09 | 2.52 | 1.20 | 5.78 | 9.10 |
PB Ratio | 5.08 | 1.80 | 4.30 | 2.14 | 5.05 | 6.22 |
P/FCF Ratio | 31.48 | -28.29 | 47.79 | -3.54 | -40.68 | -10.91 |
P/OCF Ratio | 31.48 | -31.45 | 43.45 | -3.69 | -41.71 | -11.28 |
OCF/S Ratio | 8.76 | -3.47 | 5.81 | -32.42 | -13.87 | -80.63 |
Debt / Equity Ratio | 0.10 | 0.16 | 0.22 | 0.20 | 0.09 | 0.17 |
Quick Ratio | 2.89 | 3.64 | 2.81 | 3.62 | 3.84 | 7.43 |
Current Ratio | 4.06 | 5.31 | 3.98 | 5.85 | 5.70 | 11.44 |
Asset Turnover | 1.38 | 1.26 | 1.20 | 0.91 | 0.58 | 0.46 |
Interest Coverage | 1.15K | 6 | -796.50 | -216.75 | -79.32 | -38.86 |
Return on Equity | 11.70% | 0.86% | -18.84% | -132.01% | -35.12% | -38.06% |
Return on Assets | 8.75% | 0.66% | -13.28% | -67.12% | -23.27% | -25.75% |
Return on Invested Capital | 10.07% | 0.05% | -15.63% | -43.46% | -20.55% | -24.09% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 61.13% | 61.59% | 59.03% | 47.43% | 55.13% | 57.39% |
Net Profit Margin | 6.35% | 0.52% | -11.06% | -74% | -40.20% | -55.67% |
Pretax Profit Margin | 6.42% | 0.63% | -11.06% | -42.88% | -27.25% | -52.87% |
Operating Profit Margin | 6.10% | 0.04% | -11.19% | -43.46% | -31.83% | -49.94% |
FCF Margin | 8.76% | -3.86% | 5.28% | -33.79% | -14.22% | -83.42% |
EBITDA Margin | 7.17% | 1.60% | -9.54% | -36.95% | -24.38% | -49.15% |
Add to Watchlist
Select watchlists to add or remove NEPH